From a biomedical standpoint, how do the authors account for the biological complexity of the oral environment, such as enzymatic degradation, salivary interactions, and microbial biofilm formation, which may significantly influence the long-term biocompatibility and mechanical integrity of these materials? Would the absence of in vitro or in vivo validation risk oversimplifying these interactions and overestimating the clinical utility of the proposed formulations?
